1.Information Regarding Directors
Title | Nationality | Name | Gender and age | First Date Elected | Date Elected | Term (Years) | Education |
Chairman | R.O.C | Wei-Chyun Wong | M 51-60 | 2001.12.17 | 2022.06.21 | 3 | PHD in Chemistry, University of Pennsylvania Industrial Technology Research Institute researcher SCI Pharmtech Inc., General Manager |
Director | R.O.C | Shiang-Li Chen | M 51-60 | 2001.12.17 | 2022.06.21 | 3 | MBA, University of Georgetown Chairman of Mercuries & Associates Holding, Ltd. |
Director | R.O.C | Mercuries & Associates Holding, Ltd. Institutional representative : Aurora Chen | F 51-60 | 2001.12.17 | 2022.06.21 | 3 | MBA, University of Northwestern Polytechnic McKinsey & Company Manager |
Director | R.O.C | Mercuries & Associates Holding, Ltd. Institutional representative : Wen-Chin Chou | M 51-60 | 2001.12.17 | 2022.06.21 | 3 | PHD of Chemistry, National Taiwan University DCB Researcher Plant Manager, SCI Pharmtech, Inc. |
Independent Director | R.O.C | Te-cheng Tu | M 61-70 | 2013.06.18 | 2022.06.21 | 3 | MBA, University of Houston President of President International Development |
Independent Director | R.O.C | Chia-Chun Jay Chen | M 51-60 | 2015.06.12 | 2022.06.21 | 3 | PHD of Chemistry, Unviversity of Harvard Professor/Associate Professor, National Taiwan Normal University Associate Professor, National Chung Cheng University |
Independent Director | R.O.C | Vincent Wang | M 41-50 | 2022.06.21 | 2022.06.21 | 3 | Double Major Master's Degree of Finance and Entrepreneurship Management, Wharton School of the University of Pennsylvania Director, EASYCARD Corp. and TAIWAN SUGAR Corp. Director of TVCA |
2. The Diversification Policy
Directors | Gender | Age range | Business Management | Leadership | Industrial Knowledge | Financial and Accounting |
Wei-Chyun Wong | M | 51-60 | V | V | V | V |
Shiang-Li Chen | M | 51-60 | V | V |
| V |
Aurora Chen | F | 51-60 | V | V |
| V |
Wen-Chih Chou | M | 51-60 | V | V | V |
|
Te-cheng Tu | M | 51-60 | V | V |
| V |
Chia-Chun Jay Chen | M | 51-60 |
|
| V |
|
Vincent Wang | M | 41-50 | V | V |
| V |
The company is a pharmaceutical company, and the professional diversity goal in the composition of the Board of Directors is targeted at more than one-third of the members as professionals in management,chemistry, and chemical engineering. The company’s Board of Directors is currently composed of 7 Directors, 4 of them are the legal representatives of the parent Mercuries & Associates Holding, Ltd. 2 of them are professionals in finance, accounting, and operational management, another 2 of them are chemistry professionals concurrently serving as the senior executives of the company. As for the 3 Independent Directors, one of them is a professional in chemistry and chemical engineering which is required for the company’s nature of business, and the other 2 are professionals in finance and accounting in accordance with the law. The composition of the Board of Directors meets the diversity goal stated above.
Note2 : The proportion of Directors who are employees is 28.6%; the proportion of Independent Directors is 42.9%; the proportion of female Directors is 14.3%; as for the term of office of Independent Directors, 2 of them served between 1 ~ 3 terms and 1 of them served more than 3 terms.
Note3 : The company emphasizes gender equality in the composition of its Board of Directors, and the goal is to have more than 25% (included) of female Directors. The company is planning to add one female Director to the Board of Directors in the next term to achieve the target.